The Biotechnology Deals and Alliances of 2014 report provides comprehensive understanding and unprecedented access to the partnering deals and agreements entered into by the worlds leading healthcare companies during 2014.
Using these reports, dealmakers will effectively and efficiently gain insight into the partnering activities of the past year. The report series allows you to view all the partnering and alliances deals announced worldwide.
The initial chapters of this report provide an orientation of 2014’s dealmaking and business activities.
Chapter 1 provides an overview of the trends in dealmaking during 2014 covering trends by deal type, technology type and therapeutic indication.
Chapter 2 provides a comprehensive listing of deals by average headline, upfront, milestone and royalty rate payments
Chapter 3 provides a comprehensive listing of leading deals of 2014 listed by most active dealmakers and top deals by value, as well as contract documents available in the public domain. Each deal title links via Weblink to an online version of the deal record and where available, the contract document, providing easy access to each contract document on demand.
Chapter 4 provides a comprehensive directory of all partnering deals announced during 2014. The chapter is organized by company A-Z, deal type (collaborative R&D, co-promotion, licensing etc), therapy area and technology type. Each deal title links via Weblink to an online version of the deal record and where available, the contract document, providing easy access to each contract document on demand.
The report also includes numerous tables and figures that illustrate the trends and activities in partnering and dealmaking during 2014. In conclusion, this report provides everything a prospective dealmaker needs to know about partnering in the research, development and commercialization of technologies and products during 2014.
In conclusion, this report provides everything a prospective dealmaker needs to know about partnering in the research, development and commercialization of technologies and products during 2013.
Table Of Contents
Biotechnology Deals and Alliances of 2014 Executive Summary
Chapter 1 - Trends in dealmaking during 2014
1.1 Introduction 1.2. Partnering by deal type 1.3. Partnering by industry sector 1.4. Partnering by stage of development 1.5. Partnering by technology type 1.6. Partnering by therapy area
Chapter 2 - Average financial deal terms
2.1 Deals by headline values 2.2 Deals by upfront payments 2.3 Deals by milestone payments 2.4 Deals by royalty rates
Chapter 3 - Leading deals during 2014
3.1. Introduction 3.2. Most active dealmakers 3.3. Top deals by value during 2014
Chapter 4 - Partnering deals directory 2014
4.1. Introduction 4.2. Partnering 2014- Company A-Z 4.3. Partnering 2014- By deal type 4.4. Partnering 2014- By stage of development 4.5. Partnering 2014 - By technology type 4.6. Partnering 2014 - By therapy area
About Wildwood Ventures Current Partnering Current Agreements
Table of figures
Figure 1: Partnering by deal type during 2014 Figure 2: Partnering by industry sector during 2014 Figure 3: Partnering by stage of development during 2014 Figure 4: Partnering by technology type during 2014 Figure 5: Partnering by therapy area during 2014 Figure 6: Partnering deals with a headline value Figure 7: Partnering deals with upfront payment values Figure 8: Partnering deals with milestone payments Figure 9: Partnering deals with royalty rates, % Figure 10: Partnering by dealmaking activity during 2014 Figure 11: Top deals by value during 2014